Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Nanomedicine & LNPs Asia 2026

Lining (Arnold) Ju's Biography



Lining (Arnold) Ju, Professor and Snow Fellow, School of Biomedical Engineering, The University of Sydney

Professor Arnold Ju is a Snow Fellow, Professor at the University of Sydney’s School of Biomedical Engineering, and Group Leader at the Heart Research Institute. In 2025, he is concurrently undertaking a Visiting Sabbatical Professorship at the University of Cambridge. Prof. Ju has established Australia's first integrated platform for mechanobiology, pioneering the "4M" approaches—Mechanics, Microscopy, Microfabrication, and Microtissue modeling—to investigate cardiovascular diseases. He has published over 100 peer-reviewed papers in top-tier journals including Science, Nature, Advanced Materials, and Nature Materials. His translational research in biomechanical nanotools and vessel-on-a-chip diagnostics has been recognized globally, earning him prestigious accolades such as the Australian Academy of Science John Booker Medal, the MIT Technology Review Innovators Under 35 Asia Pacific, and the 2025 European Biophysics Journal Prize. He holds multiple patents for 3D bioprinting, microfluidic systems, and AI-driven blood coagulation point-of-care devices.

Lining (Arnold) Ju Image

Personalized 3D Vessel-on-a-Chip and Digital Twins for Thrombotic Risk Assessment and Drug Screening

Saturday, 21 November 2026 at 12:00

Add to Calendar ▼2026-11-21 12:00:002026-11-21 13:00:00Europe/LondonPersonalized 3D Vessel-on-a-Chip and Digital Twins for Thrombotic Risk Assessment and Drug ScreeningNanomedicine and LNPs Asia 2026 in Shenzhen, ChinaShenzhen, ChinaSELECTBIOenquiries@selectbiosciences.com

This presentation will introduce state-of-the-art 3D microvessel-on-a-chip platforms designed to recapitulate patient-specific vascular anatomies. By integrating microfluidics, hydrogels, and 3D bioprinting, our laboratory has developed "Physical Twins" that model complex hemodynamic flow disturbances and biomechanical thrombosis. Combined with AI-driven "Digital Twins" mapped from clinical CT angiography, this advanced organ-on-a-chip technology enables the personalized assessment of stroke risk, high-throughput antithrombotic drug screening, and the translation of mechanobiology insights into rapid point-of-care diagnostics.


Add to Calendar ▼2026-11-21 00:00:002026-11-22 00:00:00Europe/LondonNanomedicine and LNPs Asia 2026Nanomedicine and LNPs Asia 2026 in Shenzhen, ChinaShenzhen, ChinaSELECTBIOenquiries@selectbiosciences.com